Please login to the form below

Not currently logged in
Email:
Password:

Merck & Co selects Ireland for USD 280m biologics site

Merck & Co locates its site for a new vaccines and biologics facility in the Republic of Ireland with an investment of USD 280m

US-based Merck & Co has located its site for a new vaccines and biologics facility in the Republic of Ireland with an investment EUR 200m (USD 280m).

The plant is scheduled to begin operations by 2011 and will employ 170 people across production, engineering, R&D, quality control, management and administration.

Ireland's Industrial Development Agency (IDA) said that Merck & Co's decision was a very significant consolidation of Ireland's high profile position as a successful location for substantial biotechnology global investments.

The 65-acre IDA Business and Technology Park is located in Carlow and will be Ireland's first stand-alone human vaccine project. The new facility will perform formulation and sterile filling activities, as well as conducting R&D operations to support recently launched vaccines and future projects.

According to the IDA, Merck & Co, which operates as Merck, Sharp and Dohme in the country, will also recruit local academic talent to leverage opportunities in developing biologic products.

Merck & Co, who already has two other plants in Ireland, joins Abbott which operates seven sites, Johnson & Johnson with six, Pfizer with five and Schering Plough and GlaxoSmithKline (GSK) which both have four sites.

29th November 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...